These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15712179)

  • 21. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
    Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
    J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
    Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
    Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis.
    Ougolkov A; Yamashita K; Bilim V; Takahashi Y; Mai M; Minamoto T
    Int J Colorectal Dis; 2003 Mar; 18(2):160-6. PubMed ID: 12548420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer.
    Yonemura Y; Ninomiya I; Kaji M; Sugiyama K; Fujimura T; Tsuchihara K; Kawamura T; Miyazaki I; Endou Y; Tanaka M
    Anal Cell Pathol; 1995 Mar; 8(2):177-90. PubMed ID: 7786814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of dysadherin and E-cadherin expression in patients with head and neck cancer treated by radiation therapy.
    Muramatsu H; Akimoto T; Maebayashi K; Kita M; Mitsuhashi N
    Anticancer Res; 2008; 28(6B):3859-64. PubMed ID: 19192641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of peroxisome proliferator-activated receptor gamma, E-cadherin and matrix metalloproteinases-2 in gastric carcinoma and lymph node metastases.
    He Q; Chen J; Lin HL; Hu PJ; Chen MH
    Chin Med J (Engl); 2007 Sep; 120(17):1498-504. PubMed ID: 17908458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E-cadherin expression in upper urothelial carcinoma in Balkan Endemic Nephropathy and non-endemic regions.
    Velickovic LJ; Hattori T; Visnjic M; Dimov I; Stojanovic M; Stefanovic V
    Pathol Res Pract; 2009; 205(10):682-9. PubMed ID: 19446405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies.
    Becker KF; Kremmer E; Eulitz M; Schulz S; Mages J; Handschuh G; Wheelock MJ; Cleton-Jansen AM; Höfler H; Becker I
    J Pathol; 2002 Aug; 197(5):567-74. PubMed ID: 12210074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain.
    Rodriguez-Sanjuan JC; Fontalba A; Mayorga M; Bordin MC; Hyland SJ; Trugeda S; Garcia RA; Gomez-Fleitas M; Fernandez F; Caldas C; Fernandez-Luna JL
    Eur J Surg Oncol; 2006 Dec; 32(10):1110-3. PubMed ID: 16870389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
    Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
    Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
    J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer.
    Musiał J; Sporny S; Nowicki A
    Pol J Pathol; 2007; 58(4):235-43. PubMed ID: 18459457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS; Han J; Shim YM; Park J; Kim DH
    Cancer; 2005 Nov; 104(9):1825-33. PubMed ID: 16177988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer.
    Kwak JM; Min BW; Lee JH; Choi JS; Lee SI; Park SS; Kim J; Um JW; Kim SH; Moon HY
    Dis Colon Rectum; 2007 Nov; 50(11):1873-80. PubMed ID: 17828401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
    Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy].
    Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():148-54. PubMed ID: 10714205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
    Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.